|
1
|
Villegas VM, Hess DJ, Wildner A, et al:
Retinoblastoma. Curr Opin Ophthalmol. 24:581–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jehanne M, Brisse H, Gauthier-Villars M,
et al: Retinoblastoma: recent advances. Bull Cancer. 101:380–387.
2014.(In French). PubMed/NCBI
|
|
3
|
Aerts I, Lumbroso-Le Rouic L,
Gauthier-Villars M, et al: Retinoblastoma. Orphanet J Rare Dis.
1:31–41. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Temming P, Eggert A, Bornfeld N, et al:
Diagnosis and treatment of retinoblastoma: current strategies for
effective tumour control and preservation of vision. Klin Monbl
Augenheilkd. 230:232–242. 2013.(In German). PubMed/NCBI
|
|
5
|
Hilgendorf KI, Leshchiner ES, Nedelcu S,
et al: The retinoblastoma protein induces apoptosis directly at the
mitochondria. Genes Dev. 27:1003–1015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lai D, Visser-Grieve S and Yang X: Tumour
suppressor genes in chemotherapeutic drug response. Biosci Rep.
32:361–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarkar A and Hochedlinger K: The sox
family of transcription factors: versatile regulators of stem and
progenitor cell fate. Cell Stem Cell. 12:15–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu K, Lin B, Zhao M, et al: The multiple
roles for Sox2 in stem cell maintenance and tumorigenesis. Cell
Signal. 25:1264–1271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Teicher BA: Targets in small cell lung
cancer. Biochem Pharmacol. 87:211–219. 2014. View Article : Google Scholar
|
|
10
|
Lipka AF, Verschuuren JJ and Titulaer MJ:
SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening
for small cell lung carcinoma. Ann N Y Acad Sci. 1275:70–77. 2012.
View Article : Google Scholar
|
|
11
|
Linn Murphree A: Intraocular
retinoblastoma: the case for a new group classification. Ophthalmol
Clin North Am. 18:41–53. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cecchini MJ, Thwaites M, Talluri S, et al:
A retinoblastoma allele that is mutated at its common E2F
interaction site inhibits cell proliferation in gene targeted mice.
Mol Cell Biol. 34:2029–2045. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu R, Zhang XH, Zhang K, et al:
5-Aza-2′-deoxycytidine inhibits retinoblastoma cell by reactivating
epigenetically silenced RASSF1A gene. Int J Ophthalmol. 7:51–56.
2014.
|
|
14
|
Thériault BL, Dimaras H, Gallie BL and
Corson TW: The genomic landscape of retinoblastoma: a review. Clin
Experiment Ophthalmol. 42:33–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Madhavan J, Ganesh A and Kumaramanickavel
G: Retinoblastoma: from disease to discovery. Ophthalmic Res.
40:221–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xin GH, Zhao XH, Liu D, et al: Effect of
VEGF-targeted antisense gene therapy on retinoblastoma cell line
SO-RB50 in vitro and in vivo. Int J Ophthalmol. 5:440–447.
2012.PubMed/NCBI
|
|
17
|
Mhashilkar AM, Schrock RD, Hindi M, et al:
Melanoma differentiation associated gene-7 (mda-7): a novel
anti-tumor gene for cancer gene therapy. Mol Med. 7:271–282.
2001.PubMed/NCBI
|
|
18
|
Popovic J, Stanisavljevic D, Schwirtlich
M, et al: Expression Analysis of SOX14 during retinoic acid induced
neural differentiation of embryonal carcinoma cells and assessment
of the effect of its ectopic expression on SOXB members in HeLa
Cells. PLoS One. 9:e918522014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin IY, Chiu FL, Yeang CH, et al:
Suppression of the SOX2 neural effector gene by PRDM1 promotes
human germ cell fate in embryonic stem cells. Stem Cell Reports.
2:189–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weina K and Utikal J: SOX2 and cancer:
current research and its implications in the clinic. Clin Transl
Med. 3:192014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia X, Li X, Xu Y, et al: SOX2 promotes
tumorigenesis and increases the anti-apoptotic property of human
prostate cancer cell. J Mol Cell Biol. 3:230–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fujii T, Shimada K, Tatsumi Y, et al:
Syndecan-1 responsive microRNA-126 and 149 regulate cell
proliferation in prostate cancer. Biochem Biophys Res Commun. Nov
22–2014.(Epub ahead of print).
|
|
23
|
Chou MY, Hu FW, Yu CH and Yu CC: Sox2
expression involvement in the oncogenicity and radiochemoresistance
of oral cancer stem cells. Oral Oncol. 51:31–39. 2015. View Article : Google Scholar
|
|
24
|
Wadhwa L, Bond WS, Perlaky L, et al:
Embryonic retinal tumors in SV40 T-Ag transgenic mice contain
CD133+ tumor-initiating cells. Invest Ophthalmol Vis Sci.
53:3454–3462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Benavente CA, McEvoy J, et al: A
novel retinoblastoma therapy from genomic and epigenetic analyses.
Nature. 481:329–334. 2012.PubMed/NCBI
|
|
26
|
Seigel GM, Campbell LM, Narayan M and
Gonzalez-Fernandez F: Cancer stem cell characteristics in
retinoblastoma. Mol Vis. 11:729–737. 2005.PubMed/NCBI
|
|
27
|
Seigel GM, Hackam AS, Ganguly A, et al:
Human embryonic and neuronal stem cell markers in retinoblastoma.
Mol Vis. 13:823–832. 2007.PubMed/NCBI
|
